GlassScriptPhysician profile
Christian A Mcneely
NPI 1720469851
$19,839.00
in general payments reported to CMS, 2019-2025
30 companies · $4,006 in 2025
The $4,006 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,046 · 2020: $471 · 2021: $3,143 · 2022: $4,215 · 2023: $3,836 · 2024: $3,121 · 2025: $4,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,257 · Travel and Lodging: $1,706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,257.38 |
| Travel and Lodging | $1,705.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $3,247.08 | 2020-2025 | (9520) Igt Devices Undivided, Coronary Undivided, Coronary Other |
| Abiomed | $2,958.31 | 2019-2025 | Impella |
| Medtronic, INC. | $2,512.82 | 2021-2025 | Onyx Frontier |
| Boston Scientific Corporation | $1,896.08 | 2019-2025 | General - Therapies, Avvigo Guidance System, Rotapro |
| Cardiovascular Systems INC. | $1,568.78 | 2019-2023 | Diamondback Coronary |
| Abbott Laboratories | $1,448.53 | 2020-2024 | Mitraclip, Diamondback Coronary, Amplatzer |
| Shockwave Medical, INC | $1,354.38 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $1,025.59 | 2021-2025 | Orsiro Mission |
| Asahi Intecc USA, INC. | $503.14 | 2022-2024 | Peripheral Vascular, Asahi Ptca Guide Wire |
| Astrazeneca Pharmaceuticals LP | $502.22 | 2019-2024 | Brilinta, Farxiga |
| Heartflow, INC. | $415.89 | 2019-2025 | |
| Penumbra, INC. | $362.25 | 2022-2025 | Indigo System |
| Terumo Medical Corporation | $328.96 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $321.52 | 2019-2024 | Lifevest |
| Teleflex LLC | $254.08 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $189.98 | 2021 | |
| Recor Medical INC | $158.48 | 2025 | Paradise Ultrasound Renal Denervation System |
| Chiesi USA, INC. | $132.02 | 2021 | |
| Medtronic Vascular, INC. | $131.18 | 2020 | |
| Novartis Pharmaceuticals Corporation | $105.18 | 2023-2024 | |
| Amgen INC. | $101.66 | 2022-2025 | Repatha |
| Pfizer INC. | $95.54 | 2022-2024 | |
| Allergan, INC. | $77.03 | 2020 | |
| Edwards Lifesciences Corporation | $34.50 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cvrx, INC. | $27.77 | 2023 | Barostim Neo System |
| Verge Medical, INC. | $23.16 | 2023 | |
| Livanova USA, INC. | $20.90 | 2023 | Lifesparc |
| Impulse Dynamics (USA) INC. | $18.11 | 2022 | |
| Scpharmaceuticals INC. | $14.25 | 2025 | |
| Endotronix, INC. | $9.61 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Mcneely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.